{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:02:50Z","timestamp":1792551770134,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.trecan.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T17:43:45Z","timestamp":1556905425000},"page":"272-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["ADAR and Immune Silencing in Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Alan","family":"Herbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2019.03.004_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2019.03.004_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fcell.2017.00101","article-title":"Therapy for cancer: strategy of combining anti-angiogenic and target therapies","volume":"5","author":"Comunanza","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.biochem.71.110601.135501","article-title":"RNA editing by adenosine deaminases that act on RNA","volume":"71","author":"Bass","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.trecan.2019.03.004_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm.2015.4","article-title":"A-to-I editing of coding and non-coding RNAs by ADARs","volume":"17","author":"Nishikura","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1275","article-title":"The four Rs of RNA-directed evolution","volume":"36","author":"Herbert","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2019.03.004_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41576-018-0006-1","article-title":"A-to-I RNA editing \u2013 immune protector and transcriptome diversifier","volume":"19","author":"Eisenberg","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.trecan.2019.03.004_bib0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon corrected gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2019.03.004_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13238-016-0334-x","article-title":"RIG-I-like receptor-induced IRF3 mediated pathway of apoptosis (RIPA): a new antiviral pathway","volume":"8","author":"Chattopadhyay","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0050","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1074\/jbc.TM118.004166","article-title":"Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses","volume":"294","author":"Samuel","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2019.03.004_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2019.03.004_bib0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2019.03.004_bib0065","first-page":"16","article-title":"Double-stranded RNA adenosine deaminase binds Z-DNA in vitro","volume":"33","author":"Herbert","year":"1995","journal-title":"Nucleic Acids Symp. Ser."},{"key":"10.1016\/j.trecan.2019.03.004_bib0070","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1073\/pnas.94.16.8421","article-title":"A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase","volume":"94","author":"Herbert","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2019.03.004_bib0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/viro.1995.1370","article-title":"Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons","volume":"210","author":"Patterson","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.trecan.2019.03.004_bib0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/dnares\/dsw031","article-title":"Z-DNA-forming sites identified by ChIP-seq are associated with actively transcribed regions in the human genome","volume":"23","author":"Shin","year":"2016","journal-title":"DNA Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s42003-018-0237-x","article-title":"Z-DNA and Z-RNA in human disease","volume":"2","author":"Herbert","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1073\/pnas.1017241108","article-title":"RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis","volume":"108","author":"Ward","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2019.03.004_bib0095","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trecan.2019.03.004_bib0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.immuni.2015.11.001","article-title":"Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development","volume":"43","author":"Pestal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2019.03.004_bib0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1346-8138.2012.01661.x","article-title":"Dyschromatosis symmetrica hereditaria","volume":"40","author":"Hayashi","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0110","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1172\/JCI62980","article-title":"MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth","volume":"123","author":"Nemlich","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2019.03.004_bib0115","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1038\/ncomms7355","article-title":"Genomic analysis of ADAR1 binding and its involvement in multiple RNA processing pathways","volume":"6","author":"Bahn","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2019.03.004_bib0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cell.2013.03.024","article-title":"ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing","volume":"153","author":"Ota","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0125","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1128\/JVI.02457-08","article-title":"ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication","volume":"83","author":"Clerzius","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-4690-10-96","article-title":"The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication","volume":"10","author":"Clerzius","year":"2013","journal-title":"Retrovirolog."},{"key":"10.1016\/j.trecan.2019.03.004_bib0135","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1042\/BCJ20160964","article-title":"ADAR1 and PACT contribute to efficient translation of transcripts containing HIV-1 trans-activating response (TAR) element","volume":"474","author":"Chukwurah","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.trecan.2019.03.004_bib0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cytogfr.2018.03.007","article-title":"ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication","volume":"40","author":"Radetskyy","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.trecan.2019.03.004_bib0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.molcel.2014.11.030","article-title":"Dicer\u2013TRBP complex formation ensures accurate mammalian microRNA biogenesis","volume":"57","author":"Wilson","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.4049\/jimmunol.1601493","article-title":"PACT facilitates RNA-induced activation of MDA5 by promoting MDA5 oligomerization","volume":"199","author":"Lui","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0160","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1101\/gad.1848209","article-title":"Dicer1 functions as a haploinsufficient tumor suppressor","volume":"23","author":"Kumar","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2019.03.004_bib0165","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1128\/MCB.21.22.7862-7871.2001","article-title":"CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain","volume":"21","author":"Poulsen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nsmb.3403","article-title":"ADAR1 controls apoptosis of stressed cells by inhibiting staufen1-mediated mRNA decay","volume":"24","author":"Sakurai","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0175","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/MCB.01519-08","article-title":"RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1","volume":"29","author":"Fritz","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0180","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1074\/jbc.M310162200","article-title":"Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2019.03.004_bib0185","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1093\/nar\/gkt750","article-title":"Proteins that contain a functional Z-DNA-binding domain localize to cytoplasmic stress granules","volume":"41","author":"Ng","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccell.2015.08.013","article-title":"The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers","volume":"28","author":"Han","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.celrep.2015.08.080","article-title":"Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors","volume":"13","author":"Paz-Yaacov","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2019.03.004_bib0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2017.07.005","article-title":"Project DRIVE. a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening","volume":"170","author":"McDonald","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0205","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41467-018-07824-4","article-title":"Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells","volume":"9","author":"Gannon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2019.03.004_bib0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2017.10.009","article-title":"The role of A-to-I RNA editing in cancer development","volume":"48","author":"Xu","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.trecan.2019.03.004_bib0215","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ccell.2018.03.026","article-title":"A-to-I RNA editing contributes to proteomic diversity in cancer","volume":"33","author":"Peng","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2019.03.004_bib0220","doi-asserted-by":"crossref","first-page":"11517","DOI":"10.18632\/oncotarget.14076","article-title":"Characterization of RNA editome in primary and metastatic lung adenocarcinomas","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2019.03.004_bib0225","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201700188","article-title":"When microRNAs meet RNA editing in cancer: a nucleotide change can make a difference","volume":"40","author":"Wang","year":"2018","journal-title":"Bioessay"},{"key":"10.1016\/j.trecan.2019.03.004_bib0230","doi-asserted-by":"crossref","first-page":"D78","DOI":"10.1093\/nar\/gky958","article-title":"Editome Disease Knowledgebase (EDK): a curated knowledgebase of editome-disease associations in human","volume":"47","author":"Niu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0235","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature09687","article-title":"Comparative and demographic analysis of orang-utan genomes","volume":"469","author":"Locke","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2019.03.004_bib0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tcb.2015.02.001","article-title":"To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes","volume":"25","author":"Li","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0245","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.it.2016.06.003","article-title":"Innate antiviral defenses independent of inducible IFN \u03b1\/\u03b2 production","volume":"37","author":"Paludan","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0250","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","article-title":"The cGAS\u2013STING defense pathway and its counteraction by viruses","volume":"19","author":"Ma","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trecan.2019.03.004_bib0255","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.15252\/embj.201796476","article-title":"Sensing of viral and endogenous RNA by ZBP1\/DAI induces necroptosis","volume":"36","author":"Maelfait","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2019.03.004_bib0260","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3389\/fimmu.2017.00878","article-title":"Role of type I and II interferons in colorectal cancer and melanoma","volume":"8","author":"Di Franco","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0265","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1073\/pnas.1301620110","article-title":"RNA-induced silencing complex (RISC) proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators","volume":"110","author":"Redfern","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2019.03.004_bib0270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fmed.2018.00244","article-title":"New insights into the long non-coding RNA SRA: physiological functions and mechanisms of action","volume":"5","author":"Sheng","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.trecan.2019.03.004_bib0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.celrep.2015.09.032","article-title":"Principles governing A-to-I RNA editing in the breast cancer transcriptome","volume":"13","author":"Fumagalli","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2019.03.004_bib0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40659-018-0185-4","article-title":"ADAR1-mediated RNA-editing of 3\u02b9UTRs in breast cancer","volume":"51","author":"Sagredo","year":"2018","journal-title":"Biol. Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101431","article-title":"Systematic identification and characterization of RNA editing in prostate tumors","volume":"9","author":"Mo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2019.03.004_bib0290","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/0008-5472.CAN-16-0834","article-title":"Transcriptional selectivity of epigenetic therapy in cancer","volume":"77","author":"Sato","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0295","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/ncomms5726","article-title":"A genome-wide map of hyper-edited RNA reveals numerous new sites","volume":"5","author":"Porath","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2019.03.004_bib0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology: Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trecan.2019.03.004_bib0305","first-page":"3369","article-title":"DNA editing in DNA\/RNA hybrids by adenosine deaminases that act on RNA","volume":"45","author":"Zheng","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cels.2017.01.013","article-title":"Permanganate\/S1 nuclease footprinting reveals non-B DNA structures with regulatory potential across a mammalian genome","volume":"4","author":"Kouzine","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.trecan.2019.03.004_bib0315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jmedgenet-2013-102038","article-title":"A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1","volume":"51","author":"Livingston","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.trecan.2019.03.004_bib0320","article-title":"Z\u03b1 mutations and Mendelian disease","author":"Herbert","year":"2019","journal-title":"OSF Preprints"},{"key":"10.1016\/j.trecan.2019.03.004_bib0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-15-69","article-title":"Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.trecan.2019.03.004_bib0330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bjd.12401","article-title":"The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria","volume":"169","author":"Zhang","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0335","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1073\/pnas.1403814111","article-title":"DICER1\/Alu RNA dysmetabolism induces caspase-8-mediated cell death in age-related macular degeneration","volume":"111","author":"Kim","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2019.03.004_bib0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.trecan.2019.03.004_bib0345","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41467-017-01458-8","article-title":"RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure","volume":"8","author":"Solomon","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2019.03.004_bib0350","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1261\/rna.038042.112","article-title":"Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR)","volume":"19","author":"Solomon","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.trecan.2019.03.004_bib0355","first-page":"3143","article-title":"Selectively constrained RNA editing regulation crosstalks with piRNA biogenesis in primates","volume":"32","author":"Yang","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0360","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2019.03.004_bib0365","first-page":"2399","article-title":"Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells","volume":"119","author":"Besch","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2019.03.004_bib0370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/cdd.2017.170","article-title":"Anti-apoptotic BCL-2 family members in development","volume":"25","author":"Opferman","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.trecan.2019.03.004_bib0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2017.10.001","article-title":"Type I interferon pathway activation in COPA syndrome","volume":"187","author":"Volpi","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0380","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0385","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.25981","article-title":"DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family","volume":"29","author":"Zech","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.trecan.2019.03.004_bib0390","doi-asserted-by":"crossref","first-page":"10530","DOI":"10.1074\/jbc.M110.177394","article-title":"The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease","volume":"286","author":"Reijns","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2019.03.004_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004358","article-title":"RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms","volume":"10","author":"Qin","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.trecan.2019.03.004_bib0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.stemcr.2017.11.020","article-title":"TRIM28-regulated transposon repression is required for human germline competency and not primed or naive human pluripotency","volume":"10","author":"Tao","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.trecan.2019.03.004_bib0405","doi-asserted-by":"crossref","first-page":"E354","DOI":"10.3390\/genes8120354","article-title":"TRIM8: making the right decision between the oncogene and tumour suppressor role","volume":"8","author":"Caratozzolo","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.trecan.2019.03.004_bib0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048662","article-title":"Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-\u03baB pathway","volume":"7","author":"Tomar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2019.03.004_bib0415","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/febs.14260","article-title":"How USP18 deals with ISG15-modified proteins: structural basis for the specificity of the protease","volume":"285","author":"Basters","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.trecan.2019.03.004_bib0420","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trecan.2019.03.004_bib0425","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/j.1460-2075.1992.tb05567.x","article-title":"Transcription of human c-myc in permeabilized nuclei is associated with formation of Z-DNA in three discrete regions of the gene","volume":"11","author":"Wittig","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2019.03.004_bib0430","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","author":"Behan","year":"2019","journal-title":"Nature"}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240580331930069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240580331930069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:20Z","timestamp":1762505360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240580331930069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S240580331930069X"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2019.03.004","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAR and Immune Silencing in Cancer","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}